Discordance of p53 mutations of synchronous colorectal carcinomas

Modern Pathology

Volumn 13, Issue 2, 2000, Pages 131-139

  Eguchi, Kouichi ^a   Yao, Takashi ^a   Konomoto, Tatsuo ^a   Hayashi, Kenshi ^b   Fujishima, Masatoshi ^c   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

P53; Single strand conformation polymorphism; Synchronous colorectal carcinomas

Indexed keywords

PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CODON; COLORECTAL CARCINOMA; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MUTATION RATE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0033953130     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880024     Document Type: Article

References (38)

1. Moertel CG, Bargen JA, Dockerty MB. Multiple carcinomas of the large intestine: a review of the literature and a study of 261 cases. Gastroenterology 1958;34:85-98.
2. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54: 4855-78.
3. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993; 53:1676-83.
4. Yang HK, Linnoila RI, Conrad NK, Krasna MJ, Aisner SC, Johnson BE, et al. TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract. Int J Cancer 1995;64:229-33.
5. Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 1995;55:135-40.
6. Kang GH, Kim CJ, Kim WH, Kang YK, Kim HO, Kim YI. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma. Lab Invest 1997;407-17.
7. Sakamoto M, Hirohashi S, Tsuda H, Shimosato Y, Makuuchi M, Hosoda Y. Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am J Surg Pathol 1989;13:1064-7.
8. Sidransky D, Frost P, Von EA, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin bladder cancer. N Engl J Med 1992; 326:737-40.
9. Lunec J, Challen C, Wright C, Mellon K, Neal DE. C-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Lancet 1992;339:439-40.
10. Kupryjanczyk J, Thor AD, Beauchamp R, Poremba C, Scully RE, Yandell DW. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease. Mod Pathol 1996;9:166-73.
11. Mok CH, Tsao SW, Knapp RC, Fishbaugh PM, Lau CC. Unifocal origin of advanced human epithelial ovarian cancers. Cancer Res 1992;52:5119-22.
12. Smit VT, Fleuren GJ, van Houwelingen JC, Zegveld ST, Kuipers-Dijkshoorn NJ, Cornelisse CJ. Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract. Cancer 1990;66: 1843-9.
13. Noguchi S, Aihara T, Koyama H, Motomura K, Inaji H, Imaoka S. Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis. Cancer 1994;74:872-7.
14. Goto K, Konomoto T, Hayashi K, Kinukawa N, Naito S, Kumazawa J, et al. P53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas. Mod Pathol 1997;10:428-37.
15. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res 1992;52:3674-8.
16. Tsuda H, Oda T, Sakamoto M, Hirohashi S. Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin. Cancer Res 1992;52:1504-9.
17. Greenstein AJ, Slater G, Heimann TM, Sachar DB, Aufses AH Jr. A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg 1986;203:123-8.
18. Koness RJ, King TC, Schechter S, McLean SF, Lodowsky C, Wanebo HJ. Synchronous colon carcinomas: molecular-genetic evidence for multicentricity. Ann Surg Oncol 1996;3: 136-43.
19. Schwartz D, Banner BF, Roseman DL, Coon JS. Origin of multiple "primary" colon carcinomas: a retrospective flow cytometric study. Cancer 1986;58:2082-8.
20. Vasen HFA, Mecklin J-P, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
21. Large intestine. In: Jass JR, Sobin LH, editors. Histological typing of intestinal tumours. 2nd ed. Berlin: Springer-Verlag; 1989. pp. 29-40.
22. Turnbull RJ, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 1967;166:420-7.
23. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118-26.
24. Hayashi K, Kukita Y, Inazuka M, Tahira T. Single-strand conformation polymorphism analysis. In: Cotton RGH, Edkins E, Forrest S, editors. Mutation detection. Oxford: Oxford University Press; 1997. pp. 7-17.
25. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
26. Suzuki Y, Sekiya T, Hayashi K. Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants. Anal Biochem 1991;192:82-4.
27. Dunn JM, Hastrich DJ, Newcomb P, Webb JC, Maitland NJ, Farndon JR. Correlation between p53 mutations and antibody staining in breast carcinoma. Br J Surg 1993;80:1410-2.
28. Delattre O, Olschwang S, Law DJ, Melot T, Remvikos Y, Salmon RJ, et al. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet 1989;2:353-6.
29. Jernvall P, Makinen M, Karttunen T, Makela J, Vihko P. Conserved region mutations of the p53 gene are concentrated in distal colorectal cancers. Int J Cancer 1997;74:97-101.
30. Hollstein M, Sidransky D, Vogelstein B, Harris CC. P53 mutations in human cancers. Science 1991;253:49-53.
31. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JK, et al. P53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
32. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-8.
33. Cunningham J, Lust JA, Schaid DJ, Bren CD, Carpenter HA, Rizza E, et al. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992;52:1974-80.
34. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-6.
35. Kikuchi YR, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, et al. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 1992;52:3965-71.
36. Lothe RA, Fossli T, Danielsen HE, Stenwig AE, Nesland IM, Gallie B, et al. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors. J Natl Cancer Inst 1992;84:1100-8.
37. Wu AH, Paganini HA, Ross RK, Henderson BE. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer 1987;55:687-94.
38. Esrig D, Spruck CH III, Nichols PW, Chaiwun B, Steven K, Groshen S, et al. P53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 1993;143:1389-97.